1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
August 6, 2026. PAR-24-174. Policy change: no non-U.S. subawards under parent grant per NOT-OD-25-104.
Global Infectious Disease Research Training Program is a grant from the Fogarty International Center at NIH that funds research training programs focused on infectious diseases predominantly endemic in or significantly impacting people in low- and middle-income countries (LMICs).
The program (D43 Clinical Trial Optional, PAR-24-174) supports training in areas such as neglected tropical diseases, HIV co-infections, emerging life-threatening infections, and infections associated with noncommunicable diseases of public health importance. The ultimate goal is to build a critical mass of independent researchers and support staff at developing country institutions.
Eligible applicants include U.S. institutions with demonstrated LMIC collaborations and foreign institutions in LMICs. Applications with non-U.S. subawards will not be accepted. The application deadline is August 6, 2026.
Get alerted about grants like this
Save a search for “Fogarty International Center at NIH” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Global Infectious Disease Research Training (D43 D71) - Fogarty International Center @ NIH Global Infectious Disease Research Training NIH’s policy on non-U.S. subawards has changed . NIH is establishing a new award structure that will prohibit foreign subawards from being nested under the parent grant. Until this policy is in place, NIH will not issue awards to domestic or foreign entities that include a subaward to a foreign entity.
Applications with non-U.S. subawards will not be accepted by NIH for review and will be automatically withdrawn. Applicants are advised not to use non-U.S. subawards.
Global Infectious Disease Research Training Program ( D43 Clinical Trial Optional) (PAR-24-174) Country eligibility for Fogarty international training grants Applicant institutions may submit more than one application, provided that each application is scientifically distinct. U.S. institutions with a demonstrated collaboration with a researcher at a LMIC institution may apply. Foreign institutions in LMICs may also apply.
Applicant institution must have robust and high-quality research ongoing in the areas proposed. D43 Eligibility Information for more details. Global Infectious Disease (GID) research training program addresses research training needs related to infectious diseases that are predominantly endemic in or impact upon people living in developing countries.
The training programs include a variety of research training options to match the needs of the developing country institution. Program focus on a major endemic or life-threatening emerging infectious disease, neglected tropical disease, infections that frequently occur as a co-infection in HIV infected individuals, or infections associated with noncommunicable disease conditions of public health importance in LMICs.
The ultimate goal is to build a critical mass of researchers and support staff to conduct independent infectious disease research in developing country institutions.
Training programs may include: Long-term (master's or doctoral degree and other training that is six months or longer) training for the full range of skills necessary to support research and research administration with the understanding that the focus of thesis and training-related research will be in their country.
Medium-term (three- to up to six-months) training or mentoring, including specialized clinical, laboratory, research or administrative/business skills necessary to support research that is planned or ongoing.
Short-term (less than three months) training or mentoring that focuses on research methodology, laboratory skills necessary to support research ethics and compliance issues, program and grants administration and financial management, grant writing, preparation of scientific manuscripts, data management, informatics, and other relevant areas.
Institutional capacity-building efforts such as in-country training workshops in advanced research techniques, distance learning and informatics. Advanced in-country mentored research undertaken by the trainee in their home country upon completion of his/her initial period of long-term training under the program.
Starting with 2019 application deadlines, D71 planning grants are eligible for up to two years of support, with increased funds for training resources, including faculty strengthening activities; development of advanced course and training resources; and training program evaluation. View a full list of Global Infectious Diseases (GID) Research Training grant awards by institution.
Division of International Training and Research Fogarty International Center National Institutes of Health 31 Center Drive, MSC 2220 Telephone: (301) 402-9467 Grants Management Specialist Fogarty International Center 31 Center Drive, MSC 2220 Satabdi. Raychowdhury@nih. gov The D43 announcement is issued by Fogarty in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) .
Nutritional research in Tanzania may help coal miners in the U.S. Global Health Matters , July/August 2025 This infectious disease expert helped build Uganda’s research infrastructure Global Health Matters , September/October 2023 Peru’s research infrastructure, supported by Fogarty, continues to blossom Global Health Matters , July/August 2023 UB, partners receive $1.
5 million NIH grant for infectious disease training program University of Buffalo news, April 11, 2023 Fogarty Grant Recipient & Trainee Publications Risk of arboviral transmission and insecticide resistance status of Aedes mosquitoes during a yellow fever outbreak in Ghana , co-authored by Fogarty grant recipient Yaw Asare Afrane BMC Infectious Diseases , July 25, 2025 Prognostics of multiple malaria episodes and nutritional status in children aged 6 to 59 months from 2013 to 2017 in Dangassa, Koulikoro region, Mali , co-authored by Fogarty grant recipient Seydou Doumbia and Fogarty trainees Soumba Keita, Mahamoudou Toure, Daouda Sanogo and Mahamadou Diakite Malaria Journal , June 13, 2024 Seroprevalence of Human T-Cell Lymphotropic Virus-1 in a Jamaican Antenatal Population and Assessment of Pooled Testing as a Cost Reduction Strategy for Implementation of Routine Antenatal Screening , co-authored by Fogarty trainees Ynolde Leys, Tiffany Butterfield, and Jacynth Moore The American Journal of Tropical Medicine and Hygiene , October 23, 2023 Resurgence of Malaria Transmission and Incidence after Withdrawal of Indoor Residual Spraying in the District of Koulikoro, Mali , co-authored by Fogarty grant recipient Seydou Doumbia and Fogarty trainees Mahamoudou Touré, Drissa Konaté, Mahamadou Diakité, and John Beier The American Journal of Tropical Medicine and Hygiene , September 6, 2023 Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh , co-authored by Fogarty grantees Stephen Calderwood, Firdausi Qadri, and Edward Ryan, and Fogarty trainees Mohammad Kamruzzaman and Richelle Charles mSphere , August 30, 2023 Amblyomma cajennense and Rhipicephalus microplus ticks collected in Colombia , co-authored by Fogarty grant recipients Patricia Aguilar and Juan Rodas, and Fogarty trainee Francisco Díaz Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants , co-authored by Fogarty grant recipients Edward T.
Ryan and Firdausi Qadri mSphere , February 23, 2024 Association of severe malaria with cognitive and behavioural outcomes in low- and middle-income countries: a meta-analysis and systematic review , co-authored by Fogarty Advisory Board member Chandy John Malaria Journal , August 3, 2023 Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-21-120) Grants awarded through PAR-21-120 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71 Clinical Trials Not Allowed) (PAR-19-362) Grants awarded through PAR-19-362 in NIH RePORTER Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-20-229) Grants awarded through PAR-20-229 in NIH RePORTER Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) (PAR-18-840) Grants awarded through PAR-18-840 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-17-058) Grants awarded through PAR-17-058 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-15-160) Grants awarded through PAR-15-160 in NIH RePORTER Global Infectious Disease Research Training Program (D43) (PAR-14-193) Grants awarded through PAR-14-193 in NIH RePORTER Global Infectious Disease Research Training Program (D71) (PAR-14-194) Grants awarded through PAR-14-194 in NIH RePORTER Global Infectious Disease Research Training Program (D43) (PAR-10-260) Grants awarded through PAR-10-260 in NIH RePORTER Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-10-262) Grants awarded through PAR-10-262 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PAR-08-154) Grants awarded through PAR-08-154 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PAR-05-128) Grants awarded through PAR-05-128 in NIH RePORTER Global Infectious Disease Research Training Program Award (D43) (PA-03-012) Grants awarded through PA-03-012 in NIH RePORTER
Based on current listing details, eligibility includes: U.S. institutions with demonstrated collaboration with LMIC researcher may apply. Foreign institutions in LMICs may also apply. Note: Per NOT-OD-25-104, applications with non-U.S. subawards under the parent grant will not be accepted. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $230,000/year direct costs for new awards; $276,000/year for renewals; max 5 years Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is August 6, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program